Cochrane Abstracts
Lipid‐lowering agents for nephrotic syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Lipid‐lowering Agents for Nephrotic Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437563/all/Lipid‐lowering_agents_for_nephrotic_syndrome.
Lipid‐lowering agents for nephrotic syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437563/all/Lipid‐lowering_agents_for_nephrotic_syndrome. Accessed January 15, 2026.
Lipid‐lowering agents for nephrotic syndrome. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437563/all/Lipid‐lowering_agents_for_nephrotic_syndrome
Lipid‐lowering Agents for Nephrotic Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437563/all/Lipid‐lowering_agents_for_nephrotic_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lipid‐lowering agents for nephrotic syndrome
ID - 437563
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437563/all/Lipid‐lowering_agents_for_nephrotic_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
